Menthacarin treatment attenuates nociception in models of visceral hypersensitivity
Neurogastroenterology & Motility · 2024
DOI: 10.1111/nmo.14760 ↗At a glance
Journal article in Neurogastroenterology & Motility, 2024. Written by Adesina Omoloye and 3 co-authors. Institution: Leicester Institute for Pharmaceutical Innovation, Leicester School of Pharmacy, De Montfort University, Leicester, UK. Major MEDLINE topics: Irritable Bowel Syndrome, Visceral Pain, Oils, Volatile. Cited 2 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Dr. Willmar Schwabe GmbH & Co.
Abstract (original language)
Background
Chronic visceral hypersensitivity is closely associated with irritable bowel syndrome (IBS), a very common disorder which significantly impairs quality of life, characterized by abdominal pain, and distension. Imaging studies have found that IBS patients show higher metabolic activities and functional differences from normal controls in the anterior cingulate cortex (ACC), in response to visceral pain stimulation. Non‐clinical data and clinical data suggest that medicinal products containing essential oils such as peppermint or caraway oil exert beneficial effects on IBS symptoms.
Methods
We assessed acute and long‐term treatment effects of a mixture of peppermint and caraway essential oils (Menthacarin) on brain electrophysiological markers of gut pain sensitivity in two rat models of visceral hypersensitivity. Key Results Chronic administration of corticosteroids and acute repeated mechanical hyperstimulation under anesthesia induced hyperalgesia and hypersensitivity, characterized by an increase in electrophysiological excitatory responses of ACC neurons to colorectal distension (CRD) and an increase in the proportion of neurons responding to otherwise subthreshold stimulation, respectively. Long‐term, but not acute, oral administration of Menthacarin (60 mg kg −1 day −1 ) significantly reduced the net excitatory response to CRD in normally responsive control animals and counteracted the development of visceral hyperalgesia and hypersensitivity induced by repeated corticosterone administration and acute mechanical stimulation. Conclusions & Inferences The present study shows that, using the CRD method, chronic Menthacarin administration at a clinically relevant dose attenuates the neuronal discharge associated with visceral pain stimuli in the rat ACC, particularly in models of hypersensitivity, suggesting a potential for treating exaggerated visceral pain sensitivity.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Leicester Institute for Pharmaceutical Innovation, Leicester School of Pharmacy, De Montfort University, Leicester, UK.
- Preclinical R&D, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany.
ORCID profiles: Benjamin Gronier
Funding
- Dr. Willmar Schwabe GmbH & Co
Cite
APA
Omoloye, A., Weisenburger, S., Lehner, M. D., & Gronier, B. (2024). Menthacarin treatment attenuates nociception in models of visceral hypersensitivity. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14760
Vancouver
Omoloye A, Weisenburger S, Lehner MD, Gronier B. Menthacarin treatment attenuates nociception in models of visceral hypersensitivity. Neurogastroenterology & Motility. 2024. doi:10.1111/nmo.14760
BibTeX
@article{Omoloye2024,
author = {Omoloye, Adesina and Weisenburger, Sabrina and Lehner, Martin D and Gronier, Benjamin},
title = {Menthacarin treatment attenuates nociception in models of visceral hypersensitivity},
journal = {Neurogastroenterology & Motility},
year = {2024},
doi = {10.1111/nmo.14760}
}
EUVIMED